Zealand Pharma A/S (ZLDPF) 6-K Company announcement – No. 06 / 2020

Exhibit 99.2

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Adam Steensberg
2.	Reason for the notification
a)	Position/status	EVP, Chief Medical and Development Officer in Zealand Pharma A/S
b)	Initial notification/Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Shares
	Identification code	DK0060257814
b)	Nature of the transaction	Sale of shares
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			DKK 191,61	14.511
d)	Aggregated information
	-     Aggregated volume		DKK 2.780.512
	-     Price
e)	Date of the transaction		18 March 2020
f)	Place of the transaction		Nasdaq Copenhagen A/S